Givaudan stock trades close to consensus target as earnings support cautious upside
Published on 08/18/2026 at 07:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Givaudan SA (ISIN CH0010645932) stock is quoted at CHF 3,211.00 per share as of August 17, 2026, leaving the Swiss fragrance and flavors specialist modestly below a CHF 3,501.33 consensus target price compiled on the same date and highlighting investors' cautious but constructive view on the shares. As of the same session, the last official closing price stood at CHF 3,225.00, providing a clear short-term reference point for the current trading range around the consensus valuation benchmark. For investors, the gap between the live quote and the target level quantifies a measured expected upside rather than an aggressive rerating story.
Price sits below consensus target
Per recent market data as of August 17, 2026, Givaudan stock trading at CHF 3,211.00 reflects how the market currently calibrates the balance between defensive cash flows and moderate growth expectations in the fragrance and flavors segment. The difference of CHF 290.33 between this quote and the CHF 3,501.33 consensus target corresponds to an upside potential of about 9.0 percent on paper, underlining that analysts' models still see room for appreciation even after the latest earnings season. At the same time, the closing price of CHF 3,225.00 shows that the shares have recently traded slightly above the latest live snapshot, suggesting intraday swings within a relatively tight band around the CHF 3,200 mark.
Market data also imply a sizable equity valuation for Givaudan, with a market capitalization in the order of CHF 32.03 billion as of mid-August 2026, underscoring the company's status as a large-cap defensive name in European specialty chemicals. Based on this valuation and the dividend metrics, the trailing dividend yield stands near 2.02 percent, combining cash distribution with perceived resilience in demand for consumer, household, and fine fragrance ingredients. For investors comparing yield and growth, the combination of a low-single-digit percentage yield and mid-single-digit expected revenue expansion yields a blended profile that competes with other staples-oriented names rather than high-growth industrials.
Earnings and revenue performance in latest half-year
The latest half-year reporting period shows that Givaudan generated revenue of CHF 3.86 billion, slightly below the CHF 3.93 billion that had been estimated beforehand and signaling a modest shortfall versus expectations. On the earnings line, the company delivered half-year earnings of CHF 63.85 per share, compared with an estimated CHF 66.04 per share, resulting in an earnings surprise of minus 3.32 percent relative to consensus. The earnings gap, while limited in magnitude, indicates that operating conditions and cost dynamics were somewhat less favorable than analysts had penciled in for the period.
Despite the small miss versus forecasts, Givaudan still reported solid underlying profit growth. Net income in the last half-year reached CHF 592.00 million, up from CHF 502.00 million reported in the previous comparable half-year and marking a 17.93 percent increase in bottom-line profitability. This double-digit advance in net income contrasts with the slight revenue miss, implying improving margins and efficiency even as top-line momentum moderated relative to expectations. The company's EBITDA stood at CHF 1.80 billion for the same period, corresponding to an EBITDA margin of 23.87 percent, which illustrates robust profitability levels in a sector where scale and formulation expertise are key competitive advantages.
Looking ahead, consensus projections for the next half-year call for earnings of CHF 59.61 per share and revenue of CHF 3.67 billion. Compared with the last reported half-year, this implies a slight expected normalization in earnings per share from CHF 63.85 to CHF 59.61 and a modest step down in revenue from CHF 3.86 billion to CHF 3.67 billion. The forecast profile suggests that analysts see Givaudan maintaining strong profitability while adjusting for potential demand headwinds and currency effects, rather than extrapolating the recent double-digit net income growth linearly into future periods.
Dividend, margins, and analyst context
Dividend income remains a notable pillar of the investment case. Givaudan pays its dividend annually, and the last dividend per share amounted to CHF 70.00, which on the current share price translates into a trailing dividend yield of 2.02 percent. This level puts the stock in a zone where income-focused investors can combine a predictable cash payout with exposure to structural demand trends in fragrances and flavors. The dividend policy also signals confidence from management in long-term cash generation, despite recent minor earnings misses versus estimates.
From a profitability perspective, the latest reported EBITDA of CHF 1.80 billion and an EBITDA margin of 23.87 percent underscore Givaudan's ability to convert a significant portion of its revenue into operating cash flows. Compared with peers in specialty chemicals and ingredients, a margin in the mid-20 percent range stands out as a sign of pricing power and mix quality, particularly in higher-margin segments such as fine fragrances and active cosmetic ingredients. The margin profile also gives the company some buffer to absorb input cost fluctuations from commodities and energy, a theme that has affected many industrial names in recent quarters.
Analyst consensus on the stock, expressed via the target price of CHF 3,501.33 against a live quote of CHF 3,211.00, can be interpreted as a cautiously constructive stance. The quantified gap of 9.0 percent upside is materially positive but not excessive, signaling that most models embed steady cash flow generation and mid-single-digit growth rather than aggressive expansion scenarios. For investors, this means that potential upside is likely to be driven by continued margin resilience, disciplined capital allocation, and incremental gains in new product categories rather than transformative acquisitions or dramatic operating leverage.
Fragrance and flavors portfolio supports earnings quality
Givaudan's business model centers on designing and producing fragrances and flavors that are embedded in a wide range of consumer goods, from perfumes and personal care products to food, beverages, and household items. A representative product family is its fine fragrance compositions, which blend aromatic compounds to create signature scents for global brands and niche perfumers alike. These formulations are often co-developed with customers and tailored to specific brand identities, making them difficult to substitute and supporting long-term supplier relationships. The fine fragrance segment, while more cyclical than basic consumer scents, tends to offer higher margins thanks to the premium positioning of the end products.
Beyond fine fragrances, Givaudan's flavors portfolio includes solutions for beverages, dairy, savory applications, and confectionery, where the company works with customers to match regional taste preferences and regulatory requirements. The breadth of the portfolio across taste and scent applications helps smooth demand across cycles, as weakness in one end-market can be offset by strength in another. This diversification contributes to the steady EBITDA margin around 23.87 percent reported in the latest half-year, as the company can leverage its R&D and manufacturing footprint across multiple segments.
Shares reflect defensive profile and valuation discipline
As of August 17, 2026, with Givaudan stock quoted at CHF 3,211.00 and a last close at CHF 3,225.00 on the SIX Swiss Exchange, investors have a clear picture of the current trading range anchored slightly below the consensus target. The quantifiable valuation gap, the CHF 70.00 dividend per share, and the 2.02 percent trailing yield combine with a CHF 32.03 billion market capitalization to define a defensive large-cap profile that appeals to investors seeking a mix of stability and moderate growth. While the recent half-year brought small misses versus revenue and EPS estimates, the 17.93 percent year-on-year increase in net income and the 23.87 percent EBITDA margin show that the earnings engine remains solid, supporting the cautious upside priced into the stock.
Read more
More on Givaudan stock can be found via recent market data pages and earnings overviews that detail consensus expectations and valuation metrics.
Flagship fine fragrance offerings
One flagship area within Givaudan's portfolio is fine fragrance creations for global perfume houses and fashion labels. These products combine proprietary aromatic molecules and natural ingredients into complex blends that define the olfactory identity of high-profile brands. Because fine fragrances are often marketed as premium, aspirational products, Givaudan can command pricing that supports the overall EBITDA margin of 23.87 percent, contributing meaningfully to the CHF 1.80 billion EBITDA reported in the latest half-year. For investors, the fine fragrance segment illustrates how brand-linked, high-value-add formulations underpin both revenue quality and margin resilience.
Stock level and investor takeaway
With Givaudan stock trading at CHF 3,211.00 as of August 17, 2026, modestly below the CHF 3,225.00 recent close and the CHF 3,501.33 consensus target, the shares encapsulate a balance between defensive earnings quality and measured upside potential. The combination of a CHF 70.00 annual dividend per share, a 2.02 percent trailing yield, net income rising from CHF 502.00 million to CHF 592.00 million, and a 23.87 percent EBITDA margin frames an investment case built on steady cash generation rather than rapid growth. For retail investors, the current price range around CHF 3,200 and the quantified gap to the target level provide concrete reference points for assessing valuation, risk, and return expectations.
Fact box
Company: Givaudan SA
ISIN: CH0010645932
Ticker: GIVN
Exchange: SIX Swiss Exchange
Price (as of August 17, 2026): CHF 3,211.00
Market cap: CHF 32.03 billion (as of August 17, 2026)
Sector / Industry: Specialty chemicals / fragrances and flavors
Index membership: Swiss Market Index (SMI)
